Transmissible spongiform encephalopathy (TSE) diseases are characterized by the accumulation in brain of an abnormal protease-resistant form of the host-encoded prion protein (PrP), PrP-res. PrP-res conformation differs among TSE agents derived from various sources, and these conformational differences are thought to influence the biological characteristics of these agents. In this study, we introduced deletions into the flexible N-terminal region of PrP (residues 34 -124) and investigated the effect of this region on the conformation of PrP-res generated in an in vitro cell-free conversion assay. PrP deleted from residues 34 to 99 generated 12-16-kDa protease-resistant bands with intact C termini but variable N termini. The variable N termini were the result of exposure of new protease cleavage sites in PrP-res between residues 130 and 157, suggesting that these new cleavage sites were caused by alterations in the conformation of the PrP-res generated. Similarly truncated 12-16-kDa PrP bands were also identified in brain homogenates from mice infected with mouse-passaged hamster scrapie as well as in the cellfree conversion assay using conditions that mimicked the hamster/mouse species barrier to infection. Thus, by its effects on PrP-res conformation, the flexible N-terminal region of PrP seemed to influence TSE pathogenesis and cross-species TSE transmission.
gents and high PK concentrations, the N-terminal third of abnormal PrP (PrP-res) up to residue 89 is digested by PK, leaving the remainder of the PrP molecule from residues 90 -231 as a protease-resistant core (2, 3) . In contrast, normal PrP (PrP-sen) is completely sensitive to PK digestion. The partial resistance of PrP-res to PK digestion is probably a result of the greater aggregation and a higher content of ␤-sheet structure of PrP-res compared with PrP-sen; however, the precise structure of PrP-res remains unknown. PrP-res molecules derived from different TSE strains or sources vary in their sites of PK cleavage (4, 5) . This variation seems to be caused by conformational differences in the PrP-res molecules and is associated with differences in the clinical phenotype and neuropathology of these TSE strains (6) .
The biological properties of human TSE disease types are also associated with variation in PrP-res conformation as detected by PrP banding patterns after PK digestion. For example, in sporadic Creutzfeldt-Jakob disease (CJD), several types of PrP-res distinguished by different PK cleavage sites have been identified. These types are influenced by PrP codon 129 genotype and they seem to correlate with differences in neuropathology and clinical phenotype (7) (8) (9) . Similar variations associated with some forms of familial CJD have also been correlated with clinical phenotype and neuropathology (10 -15) .
Despite our knowledge of the conformational variation of PrP-res present in both in vivo and in vitro situations, little is understood about the molecular contributions of different regions of PrP to this variation. In the present experiments we investigated the role of the unstructured N-terminal region of PrP in influencing the conformation of PrP-res generated in vitro in TSE strain-and species-specific reactions. The N-terminal flexible region of PrP is known to play an important role in TSE pathogenesis, because transgenic mice expressing PrP lacking residues 32-106 are not susceptible to scrapie infection (16) , and those lacking residues 32-121 develop a spontaneous cerebellar degenerative disease (17) . Our previous study demonstrated that PrP amino acid residues 94 -113 were particularly important for the efficient formation of protease-resistant PrP in a cell-free system (18) . Notably, the PK-resistant conversion products generated using these mutants had a lower molecular mass (12-16 kDa versus 18 -21 kDa using wild-type PrP), suggesting that the region from 94 to 113 might influence the conformation of PrP-res generated. However, it was unclear whether these peptides had any similarity to the lower molecular mass PrP species described in human and animal TSE diseases.
In the present study, the low molecular weight PrP conver-sion products generated from N-terminal PrP deletion mutants were characterized by immunoprecipitation using antibodies to N-and C-terminal PrP peptides. The results indicated that the region between residues 94 and 99 had a particularly strong influence on the conformation of PrP-res generated in vitro.
Mapping of the protease-resistant PrP-res bands indicated that they had intact C termini but were cleaved at several different sites between residues 130 and 157 to produce bands between 12 and 16 kDa in size, similar to those described for human sporadic CJD (19) . Residues of the N-terminal region of PrP were also shown to influence the conformation of PrP-res generated in species-and strain-specific cell-free conversion reactions.
EXPERIMENTAL PROCEDURES
Antibodies-The 3F4 mouse monoclonal antibody recognizes an epitope within hamster PrP, which includes residues 109 and 112 (20) . This antibody does not recognize wild-type mouse PrP (20) . Rabbit polyclonal antibodies R24 (anti-N; residues 23-37); R18 (residues 142-155); R30 (residues 89 -103), and R20 (anti-C; residues 218 -232) were raised against the indicated PrP peptides and recognize both hamster and mouse PrP (21) .
Western Blot-Homogenates prepared from the brain tissue of mice or hamsters infected with the 263K, RML, ME7, or 22L strains of rodent adapted scrapie were treated with PK and analyzed by Western blot as described previously (22) .
Clones-Construction of the ⌬34 -94, ⌬34 -113, ⌬34 -120, and ⌬34 -124 N-terminal deletion mutants of hamster PrP (HaPrP) has been described previously, and additional mutants deleted between residues 34 and 99 (⌬34 -99), 34 and 102 (⌬34 -102), 34 and 106 (⌬34 -106) and 34 and 110 (⌬34 -110) were generated in plasmid p23-7 using the same strategy (18) . The ⌬34 -94(LV) mutant was prepared by changing residues of HaPrP codon 109 from ATG to CTC to encode a methionineto-leucine amino acid change and codon 112 from ATG to GTG to encode a methionine to valine amino acid change. PrP deletion mutants were sequenced, subcloned into the pSFF retroviral expression plasmid and transfected into retroviral vector packaging cell lines (⌿2 and PA317) as described previously (23, 24) .
Labeling and Purification of PrP-sen-The 35 S labeling of PrP-sen in the presence or absence of tunicamycin was performed as described previously (18) . After methanol precipitation at Ϫ20°C the resulting protein precipitate was sonicated into a detergent lipid protein complex buffer (4.2 mg/ml ␣-phosphatidylcholine, 50 mM Tris-Cl, pH 7.5, and 2% sarkosyl in normal saline) and incubated overnight at 4°C with antiPrP antibodies. Wild-type hamster PrP, ⌬34 -94, ⌬34 -99, ⌬34 -102, and ⌬34 -106 were precipitated with the hamster PrP-specific monoclonal antibody 3F4. Wild-type mouse PrP, ⌬34 -94(LV), ⌬34 -110, ⌬34 -113, ⌬34 -120, and ⌬34 -124 deletion mutants were precipitated with the C-terminal rabbit anti-peptide polyclonal antibody R20. After incubation with 30 l of 10% (w/v) protein A-Sepharose prepared in lysis buffer (0.5% Triton-X100, 5 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, and 0.5% sodium deoxycholate) for 2 h at 4°C, the precipitated protein was washed once with detergent lipid protein complex buffer, twice with 50 mM Tris-HCl pH 7.0, 0.5 M NaCl, and 1% sarkosyl and once with distilled water (dH 2 O) before being eluted in 0.1 M acetic acid and stored at 4°C for use in the cell-free conversion assay.
Cell-free Conversion Assay-The cell-free conversion assay is an in vitro assay that generates de novo PrP-res by mixing a source of [ 35 S]PrP-sen with PrP-res isolated from the tissue of an infected animal. The conversion process involves the binding of PrP-sen to PrP-res followed by the induction of a conformational change that renders the [ 35 S]PrP partially resistant to digestion by PK. After PK digestion, the de novo generated PrP-res is detected by SDS-PAGE and autoradiography. The cell-free conversion assay correlates well with the speciesand strain-specific properties of PrP conversion that occur during TSE disease (4, 25, 26) . The method for cell-free conversion of PrP-sen to PrP-res has been described previously (27) . Briefly, 100 to 200 ng of PrP-res, purified from the brains of hamsters infected with the 263K, HY, or DY strain of hamster-adapted TSE, kindly provided by Greg Raymond (28) , was partially denatured by incubation in 2.5 mM guanidine hydrochloride for 1 h at 37°C and then incubated with 25,000 cpm of [ 35 S]PrP-sen in conversion buffer (0.75 M guanidine hydrochloride, 50 mM sodium citrate buffer, pH 6.0, 5 mM cetylpyridinium chloride, and 1.2% sarkosyl) at 37°C for 48 h. After incubation, 10% of the reaction was precipitated in ice-cold methanol and the remaining 90% was treated with 80 l of PK (12 g/ml) for 1 h at 37°C. These samples represented PKϪ and PKϩ samples, respectively. PK digestion was stopped by the addition of 10 l of inhibition mix [2 mg/ml thyroglobulin, 20 mM Pefabloc (Roche Applied Science)], and the product was precipitated at Ϫ20°C with 4 volumes of ice-cold methanol. The resulting precipitate was resuspended in sample buffer (2.5% SDS, 3 mM EDTA, 2% ␤-mercaptoethanol, 5% glycerol, 0.02% bromphenol blue, and 63 mM Tris-Cl, pH 6.8) and electrophoresed on a 16% Tris-glycine SDS-PAGE gel (Invitrogen). The gel was fixed and dried, and the PKϪ and PKϩ samples were quantified by phosphor autoradiographic image analysis (Storm PhosphorImager; Amersham Biosciences).
To remove glycans from PrP, the PKϪ sample (1/10 of conversion reaction) was added to 34 l of dH 2 O and treated overnight at 37°C with 1,000 U PNGaseF (New England Biolabs) in a final volume of 60 l according to the manufacturer's instructions. The PK-treated sample was centrifuged at 14,000 rpm for 20 min to pellet the PrP aggregates, the supernatant was removed, and the pellet was washed with 200 l of 0.1 M citrate buffer, pH 6.5, to remove residual PK. The sample was again centrifuged, and the resulting pellet was resuspended in 40 l of 1ϫ denaturation buffer (New England Biolabs) and treated with 1,000 U PNGaseF as described for the PKϪ sample. Thyroglobulin (10 g) was added to both the PKϪ and PKϩ samples as a carrier protein, and they were precipitated overnight at Ϫ20°C by the addition of four volumes of ice-cold methanol. The precipitated protein was then prepared for SDS-PAGE as described for the cell-free conversion assay.
In some cases after PK digestion, the protease-resistant fragments of the cell-free conversion assay were immunoprecipitated from the PKϩ sample. Briefly, the samples were centrifuged at 14,000 rpm for 15 min to pellet the PrP aggregates. The supernatant was removed and pellet was washed with 80 l of wash buffer (50 mM sodium citrate buffer, pH 6.0, 5 mM cetylpyridinium chloride, 1.2% sarkosyl, and 0.02 M Pefabloc) to remove residual PK. The sample was then centrifuged a second time and the supernatant removed. The pellet was resuspended in 40 l of 0.02 M Tris-Cl, 0.01 M EDTA, 0.5% Nonidet P-40, and 0.5% SDS and boiled for 10 min to denature the protein. The SDS was subsequently neutralized by the addition of 5 l of 10% Nonidet P-40 and 5 l of 0.5 M sodium phosphate, pH 7.5. A primary rabbit anti-PrP (R24, R18, or R20) antibody was added to the sample and incubated overnight at 4°C. The protein-antibody complexes were then immune-precipitated with 15 l of 10% (w/v) protein A-Sepharose/lysis buffer as described for immunoprecipitation of [ 35 S]PrP-sen. After washing the complexes were eluted from the beads by the addition of sample buffer and heated at 100°C for 10 min before the entire sample was run on a 16% Tris-glycine SDS-PAGE gel, fixed, dried, and visualized by phosphor autoradiographic image analysis.
RESULTS

Altered Conformation of PrP-res Generated from PrP-sen with Residues Deleted in the N-terminal
Region-We have previously shown that deletion of residues 34 to 113 in the Nterminal region of hamster PrP-sen altered the conversion efficiency and conformation of protease-resistant PrP produced in the cell-free conversion assay using PrP-res from the hamster 263K scrapie strain (18) . This conformational alteration was indicated by altered PK digestion, resulting in the presence of three or more protease-resistant bands between 12 and 16 kDa that were found in PrP-res generated from PrP-sen ⌬34 -113, but not from wild-type or ⌬34 -94 hamster PrP (18) . To determine more precisely the influence of PrP-sen residues from 94 to 113 in the generation of these 12-to 16-kDa fragments, four additional deletion mutants between 94 and 113 were generated and tested in the cell-free conversion assay (Fig. 1A) . Several PrP bands with apparent molecular masses of 12 to 16 kDa were detected at increased levels in the protease-resistant products generated from PrP with deletions at residues 34 -99 to 34 -124. Thus, it would seem that residues 94 -99 were particularly important to the conformation of the PrP-res produced in the cell-free conversion assay.
Role of Glycosylation in the Alteration of PrP-res StructureThe previous observations were made using PrP-sen that had been treated with tunicamycin to prevent glycosylation. Thus, it was possible that the differences in PK digestion pattern observed in Fig. 1A were caused by the absence of glycosylation rather than by the effect of deleted PrP residues. To investigate this matter, the cell-free conversion assay was repeated using glycosylated PrP-sen; however, after PK digestion, the protease-resistant material was treated with PNGaseF to remove glycans before SDS-PAGE analysis (Fig. 1B) . Similar to the results in Fig. 1A , an increased level of 12-16-kDa bands was seen after PK digestion of PrP-res generated from PrP deletion mutants ⌬34 -99 to ⌬34 -124 (Fig. 1B) . Because of the similarity between the 12-16-kDa bands generated in Fig. 1, A and B, we concluded that the banding pattern seen was not because of differential protection of PK cleavage sites by glycans but reflected the availability of PK cleavage sites as influenced by the folding of the polypeptide chain to form PrP-res.
C-terminal Protease-resistant Fragments of PrP-res Are Generated from PrP-sen with Deletions in the N-terminal
Region-To map the location of the PK cleavage sites that resulted in the 12-16-kDa bands, the PK-treated products of the cell-free conversion assay were immunoprecipitated with antibodies directed to epitopes at PrP residues 23-37 (anti-N) or residues 218 -232 (anti-C) (Fig. 2) . The anti-C antibody precipitated all of the protease-resistant bands generated by cell-free conversion of both wild-type hamster PrP-sen and the hamster PrP-sen deletion mutants. This suggested that the new PK cleavage points did not expose the C-terminal portion of PrP to PK digestion. Further mapping of the bands generated from the ⌬34 -124 deletion mutant with an antibody directed toward residues 142-155 (R18) indicated that the epitope of this antibody was present in the 14-kDa band but not present in the 12-kDa band (Fig. 2) . Based on the relative molecular mass of the protease-resistant bands, the approximate composition of the lower molecular mass PrP bands was as follows: 16-kDa band ϭ residues 130 -232, the 14-kDa band ϭ residues 142-232, and the 12-kDa band ϭ residues 157-232 (Fig. 2) . The absence of the 16-kDa band from the protease-resistant product of ⌬34 -120 and ⌬34 -124 suggested that the PK-cleavage site around residue 130 was not exposed in the PrP-res generated from these deletion mutants.
These conclusions were supported by immunoprecipitations using the anti-N antibody. No bands were precipitated by the anti-N antibody from PrP-res generated in vitro from wild-type hamster PrP-sen. This was consistent with the known PKcleavage point at residue 89 in PrP-res (2, 3). In contrast, the anti-N antibody precipitated an apparently full-length band for the ⌬34 -94, ⌬34 -99, and ⌬34 -102 deletion mutants (Fig. 2) .
In the original gels, a very weak signal could also be seen in four other mutants, ⌬34 -106, ⌬34 -110, ⌬34 -113, and ⌬34 -120. Therefore, the largest protease-resistant band generated from these deletion mutants had the same molecular mass as the PrP-sen from which they were derived, indicating that no internal PK cleavage had occurred. A slightly truncated band (ϳ2 kDa smaller than the largest band) was present in the lane containing the total conversion product generated from the ⌬34 -94, ⌬34 -99, and ⌬34 -102 deletion mutants. However, the anti-N antibody did not precipitate this band, and it seemed to result from PK cleavage at or around residue 34, which removed the portion of PrP recognized by this antibody. In summary, all the bands from protease-resistant PrP generated in vitro from the PrP deletion mutants had intact C termini and variable N termini caused by cleavage at several new PK sites exposed as a result of an alteration in the conformation of the newly formed PrP-res.
Effect of Species Compatibility on Conformation of PrP Generated in Vitro-TSE agents usually show preference for a particular species but can often be adapted to a new species by serial passage (29 -32) . The species barrier between mice and hamsters is particularly strong, because mice inoculated with hamster scrapie usually do not become clinically ill even after 2 years, despite evidence for extensive replication of the infectious agent (30 -32) . In previous experiments from this laboratory, cross-species conversion of PrP was studied in the cell-free conversion assay using hamster PrP-res and mouse PrP-sen and 12-16-kDa bands were detected in the protease-resistant PrP generated (25, 33, 34) . To determine whether these bands were identical to those seen after cell-free conversion using PrP deletion mutants (Fig. 2) , conversion reactions were performed using either hamster or mouse PrP-sen with hamster PrP-res, and the PK-digested conversion products were then immunoprecipitated with antibodies reactive with the PrP N or C terminus respectively. The R20 antibody to the C terminus (residues 218 -232) precipitated five bands of 12, 14, 16, 18, and 19 kDa from reactions using mouse or hamster PrP-sen (Fig.  3A) . These bands all contained an intact C terminus in that they were precipitated by the R20 serum. However, they lacked residues from the PrP N terminus (residues 23-37) because they were not immunoprecipitated by the anti-N serum (data not shown). These bands were similar to the bands characterized in Fig. 2 , which suggested that they were generated by PK cleavage at similar sites. Interestingly, the 12-16-kDa bands were found to be much more prominent in the reactions using mouse PrP-sen compared with those using hamster PrP-sen. Because these lower molecular mass bands represent cleavage of PrP-res at newly exposed sites available in PrP-res with an altered conformation, these results indicated that the PrP-res generated by cross-species conversion had an altered structure compared with PrP-res generated in homologous conversion reactions.
The similarity of the protease-resistant fragments generated in this cross-species conversion reaction to those generated by the N-terminal deletion mutants suggested that sequence differences in the N-terminal region might be important for this species-specific effect on the conformation of PrP-res generated in the cell-free conversion assay. Mouse and hamster PrP-sen differ at positions 108/109 and 111/112, and these differences have been found to cause partial interference with PrP conversion in scrapie-infected mouse tissue culture cells (35) and to prevent disease in certain mice (36) . To test whether differences at positions 109 and 112 of HaPrP could also alter PrPres conformation, these residues were mutated to the mouse residues, valine and leucine, in hamster ⌬34 -94 PrP, and this mutant was compared with unmutated hamster ⌬34 -94 PrP in FIG. 1 . Comparison of cell-free conversion using unglycosylated and glycosylated PrP-sen deletion mutants. Representative SDS-PAGE phosphor image of PKϪ (inset) and PKϩ samples of unglycosylated (A) and glycosylated (B) hamster PrP-sen after conversion in the cell-free assay with hamster PrP-res (263K). A, [ 35 S]PrP-sen was prepared in the presence of tunicamycin to produce a pool of unglycosylated PrP-sen. B, after cell-free conversion of glycosylated PrP-sen and PK treatment, samples were treated with PNGaseF to remove glycans before they were analyzed by SDS-PAGE. The weak intensity of bands generated by the ⌬34 -110 deletion mutant in B, reflects the lower input of PrP-sen in this sample (see inset). Molecular mass markers are indicated in kilodaltons. The pattern of PK cleavage fragments generated from glycosylated mutants was similar to that from unglycosylated mutants. Therefore, glycosylation did not prevent the exposure of PK cleavage sites in PrP-res generated from N-terminal deletion mutants of PrP-sen. a conversion reaction using hamster PrP-res. The ⌬34 -94 deletion mutant of hamster PrP-sen was used for this experiment because it did not generate a ragged N-terminal cleavage pattern like that of wild-type hamster PrP-res (18) . In these experiments the protease-resistant bands at 12-16 kDa were more prominent for the ⌬34 -94(LV) deletion mutant than for ⌬34 -94 (MM) (Fig. 3B) . Furthermore, similar to the crossspecies conversion reaction in Fig. 3A , there was also a significant increase in the percentage of 12-16-kDa protease-resistant PrP. Therefore, differences at positions 109 and 112 of HaPrP seemed to be in part responsible for the generation of PrP-res with an altered conformation in cross-species PrP-res formation (Fig. 3A) .
Detection of Truncated Forms of PrP-res with Intact C Termini in Mouse Scrapie
Brain-The truncated PrP-res fragments observed in our in vitro assay might be unique to the cell-free conversion system used. To test whether similar Nterminally truncated PrP-res peptides with intact C termini were produced in vivo during scrapie infection of mice and hamsters, several scrapie brain homogenates were analyzed by Western blot using antibodies reactive with the C terminus (R20) of PrP. Control immunoblots with the R30 antibody (residues 89 -103) detected the usual three glycoforms associated with PrP27-30 (Fig. 4A, bottom) . However, immunoblots with the R20 antibody detected additional bands at or below 18 kDa in PrP-res isolated from mice infected with RML and ME7 scrapie strains but not in hamsters infected with 263K (Fig. 4A,  top) . Therefore, numerous different N-terminally truncated PrP fragments with intact C termini were generated by PK digestion of PrP-res from mouse scrapie brain homogenates, and these altered forms were not merely technical artifacts of the in vitro cell-free conversion system used in our previous experiments (Figs. 1-3) .
Cross-species infection of mice with hamster scrapie strain 263K usually does not induce clinical disease. However, replication of infectivity can be detected after 1 year, and this infectivity often shows an increased ability to infect mice upon second passage (31, 32) . To study whether the PrP-res in such second passage mice had an altered conformation with exposure of new PK cleavage sites, three brain homogenates from clinically normal second passage mice sacrificed at 650 to 750 days after infection were treated with PNGase to remove carbohydrates and were then analyzed by immunoblot using R20 (anti-C) antiserum (Fig. 4B) . All three mice analyzed had evidence of PrP bands with molecular mass lower than 19 kDa, indicating that they were N-terminally truncated. Such bands were not seen in hamsters infected with the original 263K scrapie strain. Thus, the serial transmission of hamster 263K scrapie into mice generated multiple different conformations of PrP-res with differing exposure of PK cleavage sites, suggesting that altered PrP-res conformations are generated during the course of cross-species adaptation in vivo.
Influence of Residues in the N-terminal Region of PrP-sen on the Conformation of PrP-res Generated in Vitro Using the HY and DY Strains of
Hamster-adapted TME-Various biophysical and biochemical studies indicate that brain-derived PrP-res molecules generated from the HY and DY strains of hamsteradapted transmissible mink encephalopathy (TME) have different conformations (37) (38) (39) . Although the PrP-res molecules from these strains are cleaved by PK at residues 89 and 101 of PrP, respectively, the influence of different regions of PrP on these conformational differences has not been studied. In the present experiments, we examined the influence of PrP-sen residues from 34 to 124 on the in vitro conversion process using PrP-res derived from the HY and DY strains of hamsteradapted TME. As described previously (38, 39) , cell-free conversion of wild-type hamster PrP-sen with DY PrP-res produced protease-resistant bands that were 2-3-kDa lower in molecular mass than the bands generated in a parallel experiment using HY PrP-res (Fig. 5) . In contrast, in vitro conversion of the ⌬34 -94, ⌬34 -102, ⌬34 -113, and ⌬34 -124 PrP deletion mutants with DY PrP-res generated PrP-res bands with a higher molecular mass than those generated with HY PrP-res (Fig. 5) . Thus, in a cell-free conversion assay of the PrP deletion mutants with DY PrP-res, fewer PK cleavage sites were exposed in the newly generated PrP-res than in the PrP-res 35 S]PrP-sen was prepared in the presence of tunicamycin to produce a pool of unglycosylated PrP-sen. After cell-free conversion with hamster PrP-res (263K) and PK digestion, the samples were immunoprecipitated with an antibody either to residues 23-37 (R24 ϭ anti-N) or to residues 218 -232 (R20 ϭ anti-C) before SDS-PAGE analysis. The 14-kDa band was immunoprecipitated from the protease-resistant product of ⌬34 -124 with the R18 antibody (PrP residues 142-155). A sample without immune precipitation (total) is shown for comparison. Molecular mass markers are indicated in kilodaltons. Precipitation with the anti-C serum recovered all the bands found in the total samples before immunoprecipitation indicating that all bands contained the C-terminal region recognized by the antibody. The diagram shows the structures of the bands from 12 to 19-kDa. The 12-, 14-, and 16-kDa bands seemed to be generated by PK cleavage near residues 157, 142, and 130, respectively. generated with HY PrP-res. These results indicated that scrapie strains could differ in the influence of the flexible Nterminal region on the conformation of PrP-res generated.
DISCUSSION
In the current experiments, amino acid residues in the Nterminal region of hamster PrP were found to be important in the generation of PrP-res with an altered conformation. Use of a series of PrP-sen deletion mutants showed that deletion beyond residue 94 led to a gradual decrease in total PrP-res conversion (Ref. 18 and data not shown) and an increase in the percentage of PrP-res molecules that could be cleaved by PK at new internal sites, implying that this type of PrP-res had an altered folded structure. The mechanism of influence of the N-terminal region on PrP conversion and PrP-res conformation remains unknown. One possibility supported by our previous studies (18) is that the N-terminal region influences self-aggregation of PrP-sen, which may occur before conversion. On the other hand, the N-terminal region may act via its role in copper binding. Recent experiments using human and hamster PrP have demonstrated the presence of a previously unknown pHdependent copper ion binding site at the histidine residue at position 96 in PrP (40, 41) , in addition to the four copper binding sites previously found in the octarepeat region of PrP between residues 60 and 91 (42) . Possibly the absence of all five copper binding sites in PrP deletion mutant ⌬34 -99 influenced the conformation of PrP-res generated from these mutant PrP molecules. Loss of copper binding sites might also account for the differences seen in cell-free conversion using PrP-res from the HY and DY TME strains (Fig. 5) . However, a more precise understanding of the influence of the N-terminal region on PrP-res conformation will require PrP-res structural information that is not currently available. Although the N-terminal region of PrP has been deleted from many previous folding studies of PrP, recent studies showed that residues 138 -141 were essential for in vitro fibril formation by peptides containing the entire N-terminal region of PrP (23-141) (43) . Based on the present data, it would be important to include this region of the molecule in folding and other structural studies in the future.
Altered PrP-res conformations may also be important in the TSE species barrier. In experiments with an in vitro model of the species barrier using hamster PrP-res and mouse PrP-sen, we found evidence for increased amounts of PrP-res with altered conformations and exposure of new PK sites (Fig. 3) . This was similar to PrP-res generated from PrP-sen containing Nterminal deletions (Fig. 2) . In addition, the present studies demonstrated that PrP-res with different conformations and PK cleavage patterns could be generated in vivo in mice after infection with the ME7, RML and 22L strains of mouse scrapie, as well as after infection with mouse-passaged hamster scrapie ]PrP-sen from mouse and hamster was prepared in the presence of tunicamycin to produce unglycosylated PrP-sen. Radiolabeled wild-type hamster PrP-sen (Ha) and wild-type mouse PrP-sen (Mo) were each incubated with PrP-res from hamster 263K scrapie brain under conditions of the cell-free conversion assay. A, after PK digestion, the protease bands generated in the cell-free conversion assay were immunoprecipitated with the anti-C-terminal antibody (R20) as described in Fig. 2 . The proportion of total PrP-res that was composed of 12-16-kDa bands was determined by PhosphorImager analysis. Cross-species conversion using mouse PrP-sen generated a higher percentage of PrP-res with an altered conformation, resulting in 12-16-kDa bands compared with homologous conversion using hamster PrP-sen. B, the radiolabeled hamster PrP-sen deletion mutant ⌬34 -94 with wild-type hamster methionine residues at positions 109 and 112 ⌬34 -94(MM), or mouse-specific leucine and valine residues ⌬34 -94(LV), were used as the source of PrP-sen for cell-free conversion with hamster PrP-res (263K). The proportion of total PrP-res that was composed of 12-16-kDa bands was determined by PhosphorImager analysis. PrP-sen with mouse-specific residues (LV) generated a larger percent of PrP-res with an altered conformation as detected by presence of 12-16-kDa bands. strain 263K. These lower molecular mass PrP-res-derived fragments were not recognized in our earlier studies of these hamster/mouse cross-species TSE infections (31, 32) because, as shown in Fig. 4A , the antibodies used previously (3F4 and R30) do not detect these truncated forms of PrP-res. In summary, the present results suggest that these new conformations of PrP-res may be formed as a part of the cross-species adaptation process, which often occurs after forced passage of TSE infectivity in a new species.
Transgenic mice expressing PrP with deletions in the Nterminal region have also highlighted the importance of this region of PrP in its functions related to TSE agent replication and pathogenesis. Mice expressing PrP with residues 32-93 deleted (similar to hamster ⌬34 -94 studied here) remain susceptible to scrapie infection (44), albeit with longer incubation times and lower than usual infectivity titers, whereas mice expressing PrP deleted between residues 32-106 are not susceptible to infection (16) . In the current study, we showed that both ⌬34 -94 and ⌬34 -106 mutants of HaPrP were capable of cell-free in vitro conversion to a protease-resistant form. However, more PrP-res molecules with altered conformations and new PK sites were generated by the ⌬34 -106 mutant compared with the ⌬34 -94 mutant (Fig. 1) . Possibly PrP-res with an altered conformation leading to exposure of additional PK sites may be less stable in vivo resulting in less pathogenic properties and/or inability to undergo repeated cycles of amplification in vivo.
PrP-res fragments truncated at the N terminus but not at the C terminus have been observed previously in brains of human patients with E200K familial CJD (10) or sporadic Creutzfeldt-Jakob disease (45) (46) (47) . In contrast, PrP-res from patients with familial CJD associated with mutations such as P102L (11), F198S (12, 13) , and A117V (14, 15) is more often truncated at both the N and C termini. More recently, Cterminal PrP fragments have been described in PrP-res from patients with sporadic Creutzfeldt-Jakob disease (19) . These 12-and 13-kDa molecules have N termini located between residues 154 and 167 and are thus quite similar to some of the truncated N-terminal fragments described in the present results (Fig. 2) . In human prion diseases, it is unclear whether these smaller PrP-res fragments are generated from full-length PrP-sen or from the N-terminally truncated PrP-sen molecules that have been identified in some normal human brain cells (47) . Thus, N-terminally cleaved PrP-sen molecules may participate in the generation of PrP-res during TSE disease in a manner that is analogous to our conversion experiments using similarly truncated PrP-sen mutants. If this is the case, our data suggest that N-terminally truncated PrP-sen may be a source for the smaller PrP-res peptides identified in multiple human prion diseases.
It is not understood how the different conformations of PrPres that produce the protease-resistant fragments described here relate to the pathogenesis of TSE disease. However, peptides mimicking fragments of PrP-res associated with familial forms of TSE disease seem to have different mechanisms of neurotoxicity, and the same may be true for other PrP fragments found in sporadic CJD. Peptides derived from the amyloidogenic core of the 7-8-kDa PrP-res fragment present in patients with Gerstmann-Straü ssler-Scheinker syndrome (12) (13) (14) (15) , are only toxic to neurons that express PrP (48, 49) . In contrast, a larger C-terminal, protease-resistant fragment associated with familial CJD (E200K mutation) (10) and similar to those described for sporadic Creutzfeldt-Jakob disease (45) (46) (47) ) is toxic to neurons that do not express PrP (50) . That different protease-resistant peptide fragments are associated with diseases with different clinical phenotypes raises the pos- FIG. 5 . Cell-free conversion of N-terminal deletion mutants by PrP-res derived from the HY and DY strains of hamster-adapted TME. Representative SDS-PAGE phosphorimage of PKϪ (left) and PKϩ (right) samples of PrP-sen deletion mutants after cell-free conversion of unglycosylated [ 35 S] hamster PrP-sen with PrP-res of the Hyper (H) or Drowsy (D) strains of hamster-adapted TME. The differences in the banding patterns of PK cleavage products of PrP-res generated by DY versus HY PrP-res from wild-type (WT) PrP-sen and deletion mutants indicated that the conformation of these PrP-res products differed between these two strains. PrP-res generated by DY PrP-res displayed fewer PK cleavage sites than the PrP-res generated by HY PrP-res. Brain homogenates (10%) were digested with PK and analyzed by Western blot using R20 and R30 rabbit anti-PrP peptide sera directed to PrP residues 218 -232 and 89 -103, respectively, as described previously (22) . R20 antibody to the C-terminal region detected truncated PrP bands at and below 18 kDa in brain homogenates of mice infected with scrapie strains RML and ME7, but not in hamsters infected with strain 263K. B, immunoblot analysis of PNGase-treated PK-digested brain homogenates using R20 antibody to the PrP C terminus. Control scrapie-infected mice and hamsters and second-passage mice previously inoculated with brain homogenates from first passage mice given hamster scrapie strain 263K were analyzed. Variable-sized truncated PrP bands with intact C termini were detected in three mice infected with mouse-passaged 263K but not in hamsters infected with 263K (shown with no PNGase treatment).
sibility that the generation of these peptide fragments in vivo may directly influence the patterns of neuropathology that define different TSE strains. 
